GlobeNewswire

Woodbridge by Robert Mondavi Announces New Transformative Brand Positioning

Share

“From One For All” National Campaign Brings Brand’s Pioneering Spirit to the Forefront of Story and Marks a Number of Brand Firsts

LODI, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Woodbridge by Robert Mondavi, the number-three wine brand in the United States* with 40 years of history dedicated to raising the standard for everyday wines in America and globally, announces a new milestone with the launch of its new national brand campaign. The “From One For All” campaign celebrates Woodbridge founder Robert Mondavi’s pivotal role in democratizing wine. It is supported by a 360-degree integrated marketing plan backed by the largest investment in the brand’s history.

For the first time, Woodbridge by Robert Mondavi tells the winery’s powerful founding story and industry-changing vision through the lens of its iconic founder Robert Mondavi in the new “From One For All” marketing campaign. Celebrated for his achievements helping to establish California’s reputation for fine winemaking on a global scale through his extraordinary work in Napa Valley, Mr. Mondavi next turned his focus to encouraging a growing wine culture in the US. He believed that good wine shouldn’t be reserved for the wealthy, and at 65 years old he founded Woodbridge Winery in Lodi, California to be a wine for all people.

The campaign brings Robert Mondavi himself and his storied heritage to life through a captivating narrative in Woodbridge’s first ever 60-second TV commercial, as well as 15- and 30-second TV spots. In another brand first, Woodbridge will air these new advertisements during live sports gaining high visibility on ESPN and NFL Network. The brand’s digital advertising creative features compelling language including “Born From A Legend. Enjoyed By All” and a quote from Robert Mondavi “Whatever You Choose To Do, Pour Yourself Into it with Your Heart and Soul.”

“Since its founding in 1979, Woodbridge has remained steadfast in its commitment to making quality California wines of exceptional value for everyday enjoyment,” said Jaymie Schoenberg, Vice President of Marketing for Woodbridge by Robert Mondavi Wines. “We are proud to tell Woodbridge’s founding story and salute the pioneering spirit of our revolutionary leader Robert Mondavi, who’s vision made high quality wine more accessible across the globe. We know consumers are seeking a deeper connection to the brands they choose and this new strategy celebrates Woodbridge’s forty-year commitment to our consumers by reliving the history that got us here, with the backing of our largest investment yet.”

TV commercials commenced on June 17, 2019 on cable networks including; ESPN, NFL Network, TBS, HGTV, Food Network, Bravo, and FX, among others. Broadcast, digital marketing and social media ads will being rolling out across Facebook and Instagram today, June 24, 2019, through fall 2019.

“From One For All” was created by Woodbridge by Robert Mondavi’s creative agency of record, Cavalry, produced and directed by Stink Films, edited by Whitehouse Post, with Visual Effects Production by Carbon and Color by CO3. Full credits available upon request.

Woodbridge by Robert Mondavi “From One For All” TV Commercials:
60-second TV Commercial: https://www.youtube.com/watch?v=jHRtraZrGLM
30-second TV Commercial: https://www.youtube.com/watch?v=qrXte8vSQZg

For more information contact:
Kara Larmie, Woodbridge by Robert Mondavi, kara.larmie@cbrands.com

ABOUT WOODBRIDGE BY ROBERT MONDAVI WINES:
Robert Mondavi founded Woodbridge Winery near his childhood home in Lodi, California to make quality wines accessible to wine lovers across the world to enjoy as part of daily life. Mr. Mondavi’s pioneering vision for Woodbridge by Robert Mondavi has raised the standard for everyday wines in America, and has made Woodbridge one of the most beloved wines in the U.S. The trusted heritage and quality of Woodbridge by Robert Mondavi ensures you don’t need to spend more for great wine and the diverse portfolio of classic wines marked by bright fruit flavors made to complement food means there is something for everyone. For more about Woodbridge by Robert Mondavi, including food and wine pairings and recipes ideas, please visit www.WoodbridgeWines.com.

Please enjoy responsibly. © 2019 Woodbridge, Acampo, CA

*i6 Report MULO+C L52wks 4.21.19 & Purchase Metrics and Demographics Feb 2019

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Yara announces share buy-backs18.10.2019 08:02:00 CESTPress release

Oslo, 18 October 2019: Yara International ASA plans to buy back 0.5% of its outstanding shares by the end of 2019. Including the proportional redemption of shares owned by the Norwegian state, the total buyback and redemption will amount to approximately 0.8% of shares outstanding, equivalent to approximately NOK 800 million at today’s share price. Yara's targeted capital structure is a mid- to long-term Net debt/EBITDA range of 1.5-2.0 and a net debt/equity ratio below 0.60. Subject to these requirements, Yara's ordinary dividend shall be 50% of net income. Shareholder returns are distributed primarily as cash, with share buy-backs as a supplemental lever. Yara’s net debt/EBITDA as of 30 September 2019 would be close to 2.0 including the full effect of the announced buyback. The buy-backs are part of a program authorized by the Annual General meeting held 7 May 2019, which authorized Yara to buy back up to 5% (13,620,131 shares) of its share capital before its 2020 Annual General Meet

Yara med høyere resultat, operasjonell og kommersiell forbedring18.10.2019 08:00:00 CESTPressemelding

Oslo, 18. oktober 2019: Nettoresultat etter minoritetsinteresser for tredje kvartal var på USD 74 millioner (USD 0,27 per aksje), mot USD 98 millioner (USD 0,36 per aksje) for samme periode i fjor. Korrigert for valutaeffekter og spesielle poster var resultatet på USD 0,94 per aksje, mot USD 0,50 per aksje i tredje kvartal 2018. EBITDA eksklusive spesielle poster for tredje kvartal var på USD 630 millioner, opp fra USD 402 millioner ett år tidligere, og reflekterer høyere nitrogen oppgraderingsmarginer og sterke premium-leveranser. «Yara leverer betydelig bedre resultater i andre kvartal, med EBITDA eksklusive spesielle poster og IFRS 16 opp 49 %. Resultatet reflekterer lavere energikostnader, høyere produksjon og sterke premium-leveranser» sier Svein Tore Holsether, konsernsjef i Yara. «Jeg er fornøyd med at vi leverer resultatforbedring innen alle forretningsområder, med sterkest økning i New Business. Yaras avkastning fortsetter å øke, og hovedprioriteten fremover vil fortsatt være

Yara reports higher results, delivering operational and commercial improvement18.10.2019 08:00:00 CESTPress release

Oslo, 18 October 2019: Third-quarter net income after non-controlling interests was USD 74 million (USD 0.27 per share), compared with USD 98 million (USD 0.36 per share) a year earlier. Excluding currency effects and special items, the result was USD 0.94 per share compared with USD 0.50 per share in third quarter 2018 . Third-quarter EBITDA excluding special items was USD 630 million, up from USD 402 million a year earlier, mainly reflecting higher nitrogen upgrading margins and strong premium product deliveries. “Yara delivers significantly improved results in third quarter, with EBITDA excluding special items and IFRS 16 up 49%. The results reflect lower energy cost, higher production and strong premium product deliveries,” said Svein Tore Holsether, President and Chief Executive Officer of Yara. "I am pleased to see our results improve within all business segments, with the strongest increase in New Business. Our return on capital continues its positive trend, and our main priorit

SBM Offshore successful bidder for partner’s minority ownership in SBM Offshore operated FPSO companies18.10.2019 07:30:00 CESTPress release

October 18, 2019 Further to the announcement dated September 30, 2019 confirming its participation in the public sale auction of the equity ownership of Serviços de Petróleo Constellation S.A. (“Constellation”) in the lease and operating companies related to five Brazilian FPSOs (“the entities”), SBM Offshore confirms it has been formally designated as the successful bidder. Completion of the transaction remains subject to various conditions precedent, including consent from client Petrobras and approval by the local antitrust authority CADE (“Conselho Administrativo de Defesa Econômica”). The total consideration for the equity ownership, excluding associated non-recourse project debt, is c. US$150 million. The transaction includes the minority stake held by affiliated companies of Constellation in the entities related to the following five FPSOs (with Constellation’s ownership percentage in brackets): Cidade de Paraty (20%), Cidade de Ilhabela (12.75%), Cidade de Marica (5%), Cidade d

Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications18.10.2019 07:00:00 CESTPress release

Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu) The Centers for Disease Control and Prevention (CDC) defines people at high risk of serious flu complications as those who have conditions such as asthma, chronic lung disease, diabetes, heart disease or morbid obesity, or adults 65 years of age or older1 Basel, 18 October 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older who have been symptomatic for no more than 48 hours and who are at high risk of developing flu-related complications. Xofluza is a first-in-class, one-dose oral medicine with a novel proposed mechanism of action that inhibits polymerase acidic endonuclease, an enzyme

Beter Bed Holding announces sale and lease-back of the distribution center in Uden18.10.2019 07:00:00 CESTPress release

Highlights: Beter Beheer B.V., the wholly owned subsidiary of Beter Bed Holding, has entered into a sale-and-leaseback transaction with an investment entity advised by Tristan Capital Partners for its 72,750 square meters property in Uden for a cash consideration of € 14.0 million. This sale-and-leaseback transaction shows the long-term commitment of the Benelux operations of Beter Bed Holding to continue operating in its current distribution center and headquarter. This transaction substantially improves the liquidity and net debt position of Beter Bed Holding. The cash proceeds will be used to (i) reduce the debt position of Beter Bed Holding, and (ii) to invest in further accelerating the growth of the successful Benelux operations. John Kruijssen, CEO of Beter Bed Holding, comments: “During the past couple of months we have been working hard to strengthen our liquidity position and substantially reducing our net debt level. Together with the recently announced agreement on the dive